Recently, artificial intelligence (AI ) company OpenProtein.AI announced its partnership with large pharmaceutical ...

Andelyn Biosciences and ENCell collaborate to streamline gene therapy development, leveraging US–APAC networks for faster ...

EU Biotech Act I simplifies trials, boosts biomanufacturing, and aims for €10B investment to strengthen Europe's health ...

ISPE names 2026 FOYA winners, including AstraZeneca, Takeda, Bayer, and more, recognized for innovation, sustainability, and ...

Explore how modular facilities and single-use technologies enable scalable, compliant biomanufacturing for global commercial ...

Acumetis, formed by merging five firms, offers strategic support for life sciences, with 350 experts across 50+ markets and ...

The US Pharmacopeia highlights risks of Red Sea trade disruptions, impacting US drug supplies, with 73% of flumazenil APIs ...

Plasmid DNA is critical for cell and gene therapies, but scaling high-purity production remains challenging as CDMO partners ...

Regeneron and Telix join forces in a 50/50 collaboration to develop and commercialize next-gen radiopharmaceuticals, ...

Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...

Middle East conflict disrupts pharma supply chains, raising costs and risking shortages of key medicines globally.